• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Pharmacyclics Inc

+ Add to Watchlist

PCYC:US

117.4300 USD 3.1100 2.58%

As of 20:10:00 ET on 09/30/2014.

Company Profile for Pharmacyclics Inc (PCYC)

Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs.

Contact Information

Pharmacyclics Inc

995 East Arques Avenue
Sunnyvale, CA 94085-4521
United States
Phone: 1-408-774-0330
Fax: 1-408-774-0340

Key Executives for Pharmacyclics Inc (PCYC)

Robert W Duggan "Bob"Chairman/CEOManmeet SoniChief Financial Officer
Mahkam Zanganeh "Maky"Chief Operating OfficerShawn Cline TomaselloChief Commercial Officer
Jesse McGreivyChief Medical OfficerMaria FardisChief:Oncology Ops & Alliances
Heow TanChief:Quality Technical OpsGregory R WadeExec VP:Business Development
Rainer M Erdtmann "Ramses"Senior VP:Investor RelationsRichard Love "Rick"VP/Secretary/General Counsel
Matthew D OuttenVP:Commercial Operations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil